Diffuse Pediatric Type High Grade Glioma H3 Wildtype And Idh Wildtype

1

Review clinical trials related to Diffuse Pediatric Type High Grade Glioma H3 Wildtype And Idh Wildtype. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of 177Lu-PSMA-617 in People With Gliomas

The researchers are doing this study to find out whether the radiopharmaceutical therapy (RPT) 177Lu-PSMA-617 is a safe treatment for people with IDH wild type glioma.

Participants needed: 20
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Memorial Sloan Kettering Cancer CenterUpdated: Jun 4, 2026Locations: 7
Eligibility criteria

Diffuse astrocytoma, IDH-wildtype (grade 2-4) [+17]

Patient known to harbor any other non-canonical IDH mutations (i.e., non-R132H) [+16]